Press release
Assessing Huntington's Disease Pipeline: Clinical Trials, Drug Evolution through Stages, Targets, Mechanisms of Action (MOA), Routes of Administration (RoA), Molecule Types, and Major Companies by DelveInsight
Huntington's Disease Pipeline
"Huntington's Disease Pipeline Insight, 2023" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Huntington's Disease Market.
The Huntington's Disease Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the drug, including the mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, collaborations, mergers acquisition, funding, designations, and other product-related details.
Request a sample report @ https://www.delveinsight.com/report-store/huntingtons-disease-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Some of the key takeaways from the Huntington's Disease Pipeline Report:
• Huntington's Disease Companies across the globe are diligently working toward developing novel Huntington's Disease treatment therapies with a considerable amount of success over the years.
• Huntington's Disease companies working in the treatment market are Novartis, Roche, Ionis Pharmaceuticals, Sage Therapeutics, PTC Therapeutics, Prilenia Therapeutics, Neurocrine Biosciences, UniQure Biopharma, Vaccinex, Annexon, WaVe Life Sciences, Neurimmune Therapeutics, SOLA Biosciences, Azevan Pharmaceuticals, Annexon Inc., Luye Pharma Group Ltd., BrainStorm Cell Therapeutics, Voyager Therapeutics, Asklepios BioPharmaceutical, Passage Bio, Locana Bio, Ceptur Therapeutics, Enzerna Biosciences, AFFiRiS AG, Arvinas, Atalanta Therapeutics, Anima Biotech, SOM Innovation Biotech SA, and others are developing therapies for the Huntington's Disease treatment
• Emerging Huntington's Disease therapies in the different phases of clinical trials are Valbenazine, Tominersen, ANX-005, Branaplam, Pridopidine, WVE-003, Pepinemab, AMT 130, SAGE-718, SOL-176, PTC-518, ANX005, NI-302, RO7234292, SRX246, SOM3355, Bevantolol, BV-101 Gene Therapy, LPM3770164, Passage Bio Research Project, BrainStorm Research Project, Huntington disease Research Project, Locana Huntington disease Research Project, Ceptur Huntington Research Project, HTT RNA Research project, mHTT Research Project, AFFiRiS Huntington Research Project, HTT Research Project, and Anima Biotech mHTT Research Project, and others are expected to have a significant impact on the Huntington's Disease market in the coming years.
Huntington's Disease Overview
Huntington's disease is a hereditary neurodegenerative disorder that affects the brain's nerve cells, leading to progressive physical, cognitive, and psychiatric symptoms. It is caused by a genetic mutation that results in the production of abnormal huntingtin protein, which accumulates in the brain, causing damage. Symptoms usually appear in mid-life and worsen over time, including involuntary movements, impaired coordination, cognitive decline, and behavioral changes. There is currently no cure for Huntington's disease, and treatment focuses on managing symptoms and providing supportive care. Genetic testing and counseling are important for individuals with a family history of the disease.
Get a Free Sample PDF Report to know more about Huntington's Disease Pipeline Therapeutic Assessment- https://www.delveinsight.com/sample-request/huntingtons-disease-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Emerging Huntington's Disease Drugs Under Different Phases of Clinical Development Include:
• Pridopidine: Prilenia Therapeutics
• RO7234292: Roche
• Tominersen: Ionis Pharmaceuticals
• Valbenazine: Neurocrine Biosciences
• ANX-005: Annexon
• Pepinemab: Vaccinex
• SRX246: Azevan Pharmaceuticals
• SAGE-718: SAGE Therapeutics
• WVE-003: WaVe life Sciences
• AMT 130: UniQure Biopharma
• LPM3770164: Luye Pharma Group
• SOL-175: SOLA Biosciences
• And Others.
Huntington's Disease Route of Administration
Huntington's Disease pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs, such as
• Oral
• Parenteral
• Intravitreal
• Subretinal
• Topical
Huntington's Disease Molecule Type
Huntington's Disease Products have been categorized under various Molecule types, such as
• Monoclonal Antibody
• Peptides
• Polymer
• Small molecule
• Gene therapy
Huntington's Disease Pipeline Therapeutics Assessment
• Huntington's Disease Assessment by Product Type
• Huntington's Disease By Stage and Product Type
• Huntington's Disease Assessment by Route of Administration
• Huntington's Disease By Stage and Route of Administration
• Huntington's Disease Assessment by Molecule Type
• Huntington's Disease by Stage and Molecule Type
DelveInsight's Huntington's Disease Pipeline Report covers around 50+ products under different phases of clinical development like
• Late-stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I)
• Pre-clinical and Discovery stage candidates
• Discontinued & Inactive candidates
• Route of Administration
Further Huntington's Disease product details are provided in the report. Download the Huntington's Disease pipeline report to learn more about the emerging Huntington's Disease therapies - https://www.delveinsight.com/sample-request/huntingtons-disease-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Some of the key companies in the Huntington's Disease Therapeutics Market include:
Key Huntington's Disease companies developing therapies are Novartis, Roche, Ionis Pharmaceuticals, Sage Therapeutics, PTC Therapeutics, Prilenia Therapeutics, Neurocrine Biosciences, UniQure Biopharma, Vaccinex, Annexon, WaVe Life Sciences, Neurimmune Therapeutics, SOLA Biosciences, Azevan Pharmaceuticals, Annexon Inc., Luye Pharma Group Ltd., BrainStorm Cell Therapeutics, Voyager Therapeutics, Asklepios BioPharmaceutical, Passage Bio, Locana Bio, Ceptur Therapeutics, Enzerna Biosciences, AFFiRiS AG, Arvinas, Atalanta Therapeutics, Anima Biotech, SOM Innovation Biotech SA, and others.
Huntington's Disease Pipeline Analysis:
The Huntington's Disease pipeline report provides insights into
• The report provides detailed insights about companies that are developing therapies for the treatment of Huntington's Disease with aggregate therapies developed by each company for the same.
• It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Huntington's Disease Treatment.
• Huntington's Disease key companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
• Huntington's Disease Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
• Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Huntington's Disease market.
The report is built using data and information traced from the researcher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc.
Download Sample PDF Report to know more about Huntington's Disease drugs and therapies- https://www.delveinsight.com/sample-request/huntingtons-disease-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Huntington's Disease Pipeline Market Drivers
The Huntington's disease pipeline market is driven by several factors. Firstly, the urgent need for effective treatments and disease-modifying therapies for Huntington's disease patients, as there is currently no cure for the condition. This demand fuels research and development efforts to identify novel drug targets and therapeutic approaches. Secondly, advances in genetic and molecular understanding of Huntington's disease have led to the identification of potential biomarkers and therapeutic targets, facilitating the development of targeted therapies. Additionally, increased collaborations between academic institutions, pharmaceutical companies, and research organizations contribute to the accelerated development of innovative therapies. The potential for a significant market opportunity and the growing prevalence of Huntington's disease also drive the market growth, attracting investment and fostering innovation in the field.
Huntington's Disease Pipeline Market Barriers
The Huntington's disease pipeline market faces several barriers that impact the development and commercialization of new therapies. One significant barrier is the complex nature of Huntington's disease, which involves multiple genetic and molecular factors, making it challenging to identify effective treatment targets and develop therapies. The limited understanding of disease mechanisms and the lack of validated biomarkers pose challenges in clinical trial design and patient selection. Additionally, the rarity of Huntington's disease and the limited patient population available for clinical trials can hinder the timely completion of studies and the generation of robust efficacy and safety data. Regulatory hurdles, high costs associated with drug development, and the need for long-term follow-up data also pose barriers. Furthermore, the competitive landscape and the need to differentiate from existing treatment options present challenges for pipeline products seeking market approval.
Scope of Huntington's Disease Pipeline Drug Insight
• Coverage: Global
• Key Huntington's Disease Companies: Novartis, Roche, Ionis Pharmaceuticals, Sage Therapeutics, PTC Therapeutics, Prilenia Therapeutics, Neurocrine Biosciences, UniQure Biopharma, Vaccinex, Annexon, WaVe Life Sciences, Neurimmune Therapeutics, SOLA Biosciences, Azevan Pharmaceuticals, Annexon Inc., Luye Pharma Group Ltd., BrainStorm Cell Therapeutics, Voyager Therapeutics, Asklepios BioPharmaceutical, Passage Bio, Locana Bio, Ceptur Therapeutics, Enzerna Biosciences, AFFiRiS AG, Arvinas, Atalanta Therapeutics, Anima Biotech, SOM Innovation Biotech SA, and others.
• Key Huntington's Disease Therapies: Valbenazine, Tominersen, ANX-005, Branaplam, Pridopidine, WVE-003, Pepinemab, AMT 130, SAGE-718, SOL-176, PTC-518, ANX005, NI-302, RO7234292, SRX246, SOM3355, Bevantolol, BV-101 Gene Therapy, LPM3770164, Passage Bio Research Project, BrainStorm Research Project, Huntington disease Research Project, Locana Huntington disease Research Project, Ceptur Huntington Research Project, HTT RNA Research project, mHTT Research Project, AFFiRiS Huntington Research Project, HTT Research Project, and Anima Biotech mHTT Research Project, and others.
• Huntington's Disease Therapeutic Assessment: Huntington's Disease current marketed and Huntington's Disease emerging therapies
• Huntington's Disease Market Dynamics: Huntington's Disease market drivers and Huntington's Disease market barriers
Request for Sample PDF Report for Huntington's Disease Pipeline Assessment and clinical trials- https://www.delveinsight.com/sample-request/huntingtons-disease-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Table of Contents
1. Huntington's Disease Report Introduction
2. Huntington's Disease Executive Summary
3. Huntington's Disease Overview
4. Huntington's Disease- Analytical Perspective In-depth Commercial Assessment
5. Huntington's Disease Pipeline Therapeutics
6. Huntington's Disease Late Stage Products (Phase II/III)
7. Huntington's Disease Mid Stage Products (Phase II)
8. Huntington's Disease Early Stage Products (Phase I)
9. Huntington's Disease Preclinical Stage Products
10. Huntington's Disease Therapeutics Assessment
11. Huntington's Disease Inactive Products
12. Company-University Collaborations (Licensing/Partnering) Analysis
13. Huntington's Disease Key Companies
14. Huntington's Disease Key Products
15. Huntington's Disease Unmet Needs
16 . Huntington's Disease Market Drivers and Barriers
17. Huntington's Disease Future Perspectives and Conclusion
18. Huntington's Disease Analyst Views
19. Appendix
Trending Reports:
• France Healthcare Outlook Report: https://www.delveinsight.com/report-store/france-healthcare-outlook-report
• Acute Pulmonary Embolism Market: https://www.delveinsight.com/report-store/acute-pulmonary-embolism-market
• Choroidal Neovascularization Market: https://www.delveinsight.com/report-store/choroidal-neovascularization-market
• Chronic Cutaneous Ulcer Market: https://www.delveinsight.com/report-store/chronic-cutaneous-ulcer-market
• Pulse Oximeters Market: https://www.delveinsight.com/report-store/pulse-oximeters-market
• Ankylosing Spondylitis Market: https://www.delveinsight.com/report-store/ankylosing-spondylitis-as-market
• Neuroblastoma Market: https://www.delveinsight.com/report-store/neuroblastoma-market
• Eczema Market: https://www.delveinsight.com/report-store/eczema-market
• Chemotherapy Induced Thrombocytopenia Market: https://www.delveinsight.com/report-store/chemotherapy-induced-thrombocytopenia-market-size
• Ncfb Market: https://www.delveinsight.com/report-store/non-cystic-fibrosis-bronchiectasis-ncfb-epidemiology-forecast
• Pruritus Market: https://www.delveinsight.com/sample-request/cholestatic-pruritus-market
• Achondroplasia Market: https://www.delveinsight.com/report-store/achondroplasia-market
• Blood Gas And Electrolyte Analyzers Market: https://www.delveinsight.com/report-store/blood-gas-and-electrolyte-analyzers-market
• Hyperinsulinemic Hypoglycemia Market: https://www.delveinsight.com/report-store/congenital-hyperinsulinism-market
• Alpha Antitrypsin Market: https://www.delveinsight.com/blog/alpha-1-antitrypsin-deficiency-treatment-market
• Concussions Market Size: https://www.delveinsight.com/report-store/concussions-market
• Stable Angina Market: https://www.delveinsight.com/report-store/angina-angina-pectoris-market
• Allergic Conjunctivitis Market: https://www.delveinsight.com/report-store/allergic-conjunctivitis-market
• Encephalitis Market: https://www.delveinsight.com/report-store/tick-borne-encephalitis-market
• Intrahepatic Cholangiocarcinoma Market: https://www.delveinsight.com/report-store/intrahepatic-cholangiocarcinoma-market
• Acute Coronary Syndrome Market: https://www.delveinsight.com/report-store/acute-coronary-syndrome-market
• Advanced Renal Cell Carcinoma Market: https://www.delveinsight.com/report-store/advanced-renal-cell-carcinoma-rcc-market
• Angioedema Market: https://www.delveinsight.com/report-store/angioedema-market
• Anemia Market: https://www.delveinsight.com/report-store/anemia-market
• Foot And Ankle Devices Market: https://www.delveinsight.com/report-store/foot-and-ankle-devices-market
• Giant Papillary Conjunctivitis Market: https://www.delveinsight.com/report-store/giant-papillary-conjunctivitis-market
• Hepatorenal Syndrome Market: https://www.delveinsight.com/report-store/hepatorenal-syndrome-market
• Optic Neuritis Market: https://www.delveinsight.com/report-store/optic-neuritis-market
Contact Us:
Ankit Nigam
anigam@delveinsight.com
+91-9650213330
Healthcare Consulting
https://www.delveinsight.com/consulting-services
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Assessing Huntington's Disease Pipeline: Clinical Trials, Drug Evolution through Stages, Targets, Mechanisms of Action (MOA), Routes of Administration (RoA), Molecule Types, and Major Companies by DelveInsight here
News-ID: 3330327 • Views: …
More Releases from DelveInsight Business Research
Niemann-Pick Type C Pipeline Report Showcases Emerging Drugs and Leading Compani …
DelveInsight's, "Niemann Pick C Disease Pipeline Insight, 2025" report provides comprehensive insights about 10+ companies and 15+ pipeline drugs in Niemann Pick C Disease pipeline landscape. It covers the Niemann-Pick Type C pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Niemann-Pick Type C pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this…
Pemphigus Vulgaris Market Positioned for Accelerated Development Through 2034, D …
DelveInsight's "Pemphigus Vulgaris Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Pemphigus Vulgaris, historical and forecasted epidemiology as well as the Pemphigus Vulgaris market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Pemphigus Vulgaris market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Pemphigus Vulgaris Market Forecast
https://www.delveinsight.com/sample-request/pemphigus-vulgaris-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Some of the…
Osteogenesis Imperfecta Market to Evolve Rapidly Over the Next Decade by 2034, D …
The Osteogenesis Imperfecta market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Osteogenesis Imperfecta pipeline products will significantly revolutionize the Osteogenesis Imperfecta market dynamics.
DelveInsight's "Osteogenesis Imperfecta Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Osteogenesis Imperfecta, historical and forecasted epidemiology as well as the Osteogenesis Imperfecta market trends in the United…
Myopic Macular Degeneration Market Insights Highlight Expanding Outlook Till 203 …
DelveInsight's "Myopic Macular Degeneration Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Myopic Macular Degeneration, historical and forecasted epidemiology as well as the Myopic Macular Degeneration market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
The latest healthcare forecast report provides an in-depth analysis of Myopic Macular Degeneration, offering comprehensive insights into the Myopic Macular Degeneration revenue trends,…
More Releases for Huntington
AC Company in Huntington Upgrades Emergency Response Capabilities
As temperatures climb and air conditioners are pushed to their limits, many systems begin to fail under strain.
Residents searching for a dependable ac company near me [https://summersphc.com/huntington/] in Huntington, IN, may notice faster response times and improved service delivery this summer. That's because Summers Plumbing Heating & Cooling has invested in enhancing its emergency HVAC response systems to meet the rising demand for rapid cooling solutions during heatwaves and mechanical…
Reliable AC Installation Now Available for Huntington Homeowners
Whether you're upgrading from an outdated unit or installing a brand-new system, having a team that understands your specific needs is key.
When temperatures rise and older systems falter, many homeowners start looking for AC installation near me [https://www.google.com/search?ac+installation+near+me&kgmid=/g/11tp8xn78c] to find the right solution for reliable cooling. In Huntington, a trusted name now offers convenient and professional service that makes the process easier than ever. With its long-standing reputation and customer-first…
Maycon Construction Services: Premier Roofing Solutions in Huntington
Image: https://www.globalnewslines.com/uploads/2025/01/1735918960.jpg
Huntington, NY - Maycon Construction Services is revolutionizing roofing services in Huntington with a commitment to quality, durability, and customer satisfaction. Specializing in Roof Repair Huntington [https://www.google.com/maps?cid=4993935758546148342], the company ensures homes and businesses are protected from leaks, weather damage, and structural issues.
The team at Maycon Construction Services employs state-of-the-art techniques and premium materials to deliver lasting results. Their Roof Replacement Huntington [https://www.google.com/maps/place/Maycon+Construction+Services/@38.4112395,-82.36617,17z/data=!3m1!4b1!4m6!3m5!1s0x8846079778fdc4b5:0x454e061d07439bf6!8m2!3d38.4112395!4d-82.36617!16s%2Fg%2F11sqq7wlm7?authuser=0&hl=en&entry=ttu&g_ep=EgoyMDI0MTIwOC4wIKXMDSoASAFQAw%3D%3D] services are designed to provide an upgrade…
SCHOOL OF ROCK HUNTINGTON READY TO ROCK N’ ROLL
Huntington, NY (November 17, 2016) – School of Rock, the leader in performance-based music education, announces the opening of its newest school in Huntington, New York, located at 145 East Main Street, Huntington, New York 11743. Opening on November 19, the school will host a party from 11 a.m. to 4 p.m., featuring live music from School of Rock students. In addition to the opening party, School of Rock Huntington…
Huntington Beach Real Estate Agent Launches Luxury Home Buying Experience
The Malakai Sparks Group, a Huntington Beach, California-based realty agency spearheaded by president and real estate expert Malakai Sparks, announced the launch of its Huntington Beach Home Buying Experience service, which encompasses “curated experiences” from the entire Malakai Sparks Group team. Designed for the purpose of allowing prospective buyers to take in all Huntington Beach has to offer prior to purchasing a home – while making sure the area is…
Gershow Recycling of Huntington Hosts Customer Appreciation Day
On August 24, Gershow Recycling hosted its Customer Appreciation Day at its Huntington Station facility. Those in attendance received giveaways, enjoyed food, games and the chance to win raffle prizes provided by Gershow and WBAB Radio (102.3 FM), which also provided music for the event.
Gershow has eight locations in Brooklyn, New Hyde Park, Valley Stream, Freeport, Lindenhurst, Huntington Station, Bay Shore and Medford. For more information, call (631) 289-6188…
